Dr Neal Jain Discusses Type 2 Inflammation in Asthma
The majority of patients with asthma have type 2 inflammation, and the introduction of dupilumab has changed the treatment space for these patients, said Neal Jain, MD, FAAP, FAAAAI, director of research at Arizona Allergy & Immunology Research and a co-owner of Arcadia Allergy & Asthma and San Tan Allergy & Asthma.
Watch video Dr Neal Jain Discusses Type 2 Inflammation in Asthma online, duration hours minute second in high quality that is uploaded to the channel AJMCtv MJH 30 September 2020. Share the link to the video on social media so that your subscribers and friends will also watch this video. This video clip has been viewed 1,700 times and liked it 20 visitors.
